IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion
Sadiq Umar(University of Illinois Chicago), Shiva Shahrara(University of Illinois Chicago), Karol Palasiewicz(University of Illinois Chicago), David A. Fox(University of Michigan), Shiva Arami(University of Illinois Chicago), Katrien Van Raemdonck(Rega Institute for Medical Research), Brian Zanotti(Midwestern University), Michael V. Volin(Midwestern University), Nadera Sweiss(University of Illinois Chicago), Mark H. Gonzalez(University of Illinois Chicago), Vikram R. Rao(Pfizer (United States)), Bianca Romay(University of Illinois Chicago), M. Asif Amin(University of Michigan), Ryan K. Zomorrodi(University of Illinois Chicago)
Cited by 53
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217